The activity of myeloperoxidase (MPO), stored in azurophilic granules of neutrophils and released during inflammation (Anatoliotakis et al., 2013), has been shown to be increased in the plasma of patients with diabetes concomitant with coronary heart disease (Gorudko et al., 2012). This evidence concerns the gene MPO and coronary artery disorder.